Skip to main content
. 2022 Mar 4;27(5):1695. doi: 10.3390/molecules27051695

Figure 5.

Figure 5

Naringin enhances migration of HaCaT cells. (A) Naringin-induced cells migration was tested by scratch healing assays. The images in 16 h and 24 h were analyzed for gap area over time; (B) Representative transwell migration from cells treated with different conditions. Bevacizumab functions as an inhibitor for VEGF. Data are expressed as mean ± SEM and analyzed by one-way ANOVA analysis. * p < 0.05 as compared with the vehicle control group.